Literature DB >> 3098434

Pharmacokinetics of naproxen sodium.

S Moyer.   

Abstract

Naproxen sodium is a drug characterized by rapid and complete absorption after oral administration, highly protein-bound distribution, relatively simple metabolism, and renal excretion. Its pharmacokinetics are little affected by food, by dosage levels (within wide limits), or by mild renal impairment. The main mechanism of naproxen sodium action, inhibition of prostaglandin synthesis, makes the drug effective in combating pain and inflammation, while its relatively long half-life permits a two times daily dosing. The drug is well tolerated by most patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098434     DOI: 10.1177/03331024860060S409

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  5 in total

1.  Pharmacokinetic-pharmacodynamic modeling of the inhibitory effects of naproxen on the time-courses of inflammatory pain, fever, and the ex vivo synthesis of TXB2 and PGE2 in rats.

Authors:  Elke H J Krekels; Marie Angesjö; Ingemo Sjögren; Kristina Angeby Möller; Odd-Geir Berge; Sandra A G Visser
Journal:  Pharm Res       Date:  2011-02-23       Impact factor: 4.200

Review 2.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

3.  Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen.

Authors:  Carrie V Vause; Paul L Durham
Journal:  Headache       Date:  2011-12-08       Impact factor: 5.887

Review 4.  The Efficacy of Self-Management Strategies for Females with Endometriosis: a Systematic Review.

Authors:  Amelia K Mardon; Hayley B Leake; Cathy Hayles; Michael L Henry; Patricia B Neumann; G Lorimer Moseley; K Jane Chalmers
Journal:  Reprod Sci       Date:  2022-04-29       Impact factor: 3.060

Review 5.  Headache.

Authors:  N H Raskin
Journal:  West J Med       Date:  1994-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.